The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.
Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors
Open accessAbstract
Advanced protocols show potential for human stem cells (SC)-derived islets generation under planar (2D) alone or three-dimensional (3D) cultures, but show challenges in scalability, cell loss, and batch-to-batch consistency. This study explores Vertical Wheel (VW)® bioreactor suspension technology to differentiate islets from human induced pluripotent stem cells, achieving uniform, transcriptionally mature, and functional SC-islets. A 5x increase in scale from 0.1 L to 0.5 L reactors resulted in a 12-fold (15,005–183,002) increase in islet equivalent count (IEQ) without compromising islet structure. SC-islets show enriched β-cell composition (~63% CPPT + NKX6.1 + ISL1 + ), glucose responsive insulin release (3.9–6.1-fold increase), and reversed diabetes in STZ-treated mice. Single cell RNA sequencing and flowcytometry analysis confirmed transcriptional maturity and functional identity, similar to adult islets. Lastly, harvested SC-islet grafts demonstrate improved islet functionality and mature transcriptomic signatures. Overall, scale-up in VW® bioreactor technology enhances IEQ yield with minimal variability and reduced cell loss, offering a pathway for clinical-grade SC-islet production.
Overview
CoChat Summary
TL;DR
A modified 27-day, full-suspension differentiation protocol using Vertical Wheel® bioreactors generated human iPSC-derived islets that were transcriptionally and functionally islet-like and reversed diabetes in mice. A 5× vessel scale-up from 0.1 L to 0.5 L increased islet equivalent yield 12-fold without compromising islet structure.
Key findings
- Scale-up from 0.1 L to 0.5 L VW® bioreactors gave a 2.1 ± 0.09-fold increase in SC-islet clusters and a 12.2 ± 1.6-fold increase in IEQ (15,005 IEQ in 0.1 L vs 183,002 IEQ in 0.5 L), with linear S6 cell production (0.39 vs 0.41 million S6 cells per million iPSCs).
- S6w1 islets showed endocrine composition: 88.1 ± 1.8% CPPT+, 51.8 ± 2.3% CPPT+NKX6.1+, 43.6 ± 1.8% CPPT+ISL1+, 48.06 ± 0.6% INS+, 35.53 ± 0.8% GCG+, and 10.39 ± 1% SST+ cells; off-target Ki67+ was 2.23 ± 0.5%, Oct4+/Ki67+ 0.33 ± 0.1%, and CDX2+/Ki67+ 1.9 ± 0.3%.
- S6w1 islets were glucose-responsive in vitro, with a 3.9–6.1-fold increase in insulin release and static secretion of 4.9 ± 1.2 µIU/ml at high glucose vs 0.9 ± 0.2 µIU/ml at low glucose per 1000 cells; dynamic perifusion showed a peak of 6.6 ± 0.2-fold over G3.
- In STZ-diabetic SCID-beige mice, >50% of transplanted mice achieved euglycemia within 30 days and all 15 transplanted mice showed diabetes reversal by 60 days; stimulated human C-peptide increased from 0.8 ± 0.08-fold at 8 weeks to 3.10 ± 0.49-fold at 16 weeks. scRNAseq showed islet-like populations comparable to adult islets but with a fetal-like maturation phenotype.
Methods
- Three human iPSC lines from healthy, total pancreatectomy, and type 1 diabetes donors were expanded and differentiated in 0.1 L or 0.5 L PBS mini-Vertical Wheel® bioreactors using a six-stage, 27-day suspension protocol modified from Sui et al., with aphidicolin added during Stage 6.
- Characterization included brightfield/dithizone imaging, immunohistochemistry, flow cytometry, dynamic and static GSIS, TaqMan low-density array gene expression, and scRNA-seq with Seurat/Azimuth projection against human pancreas and donor islet datasets.
- In vivo testing transplanted 2500 IEQ S6w1 SC-islets under the kidney capsule of STZ-induced diabetic immunodeficient SCID-beige mice; grafts were assessed by blood glucose, IPGTT, human C-peptide, histology, flow cytometry, and gene expression up to 16 weeks.
Limitations
- The paper states that S6w1 islets remain immature with a fetal-like phenotype, show lower in vitro insulin release than adult islets, and require months of in vivo maturation; the protocol was equivalent but not superior to published protocols for in vitro functionality and maturation.
- The paper notes that aphidicolin may inhibit DNA polymerases and impair DNA repair, potentially affecting genomic stability, and suggests exploring less toxic cell-cycle inhibitors such as PD166167 and ZM426012.
- Evident from the text: randomization was not performed, although analysis was blinded; some animal groups were small (e.g., n = 4 diabetic controls, n = 15 transplanted), and long-term human clinical safety/efficacy is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 40 Not checked · 208 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“S6w1 grafts demonstrated the presence of mature all islet cell types within the engrafted tissues. These include the presence of- β-like (INS), α-like (GCG), δ-like (SST), and Ghrelin-like (GHRL) cells (Fig. 3g).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets reverse diabetes after in vivo maturation
boostedSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The improved full-suspension, six-stages (S1 through S6) differentiation process efficiently produced islet-like clusters from each of the three tested iPSC lines in small (0.1 L) to scale-up (0.5 L) vessel (Supplementary Fig. 1a).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Vertical-Wheel® suspension bioreactors promote islet cell differentiation and offers scale up capacity of human SC-islets
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunohistochemical staining demonstrated survival and engraftment of residual pancreatic progenitor cells that gradually developed into ductal or microcystic structures, possibly from contaminating non-endocrine cells (Fig. 3h).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets reverse diabetes after in vivo maturation
boostedstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Non-transplanted STZ-induced diabetic control mice (red) exhibited elevated glucose levels >20 mM over 90 days (Fig. 3b).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets reverse diabetes after in vivo maturation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Glycolysis and TCA pathway-related genes (G6PC2, GCK) were also upregulated in S6w1 mature β cells (Fig. 2e).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets show in vitro functional potential and glucose-responsive insulin release
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
114 more claims
Create a free account to see all 248 claims and to verify the 73 references still open.
- It may state two separate claims as one. 104
- Probably not a substantial claim. 37
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Discussion
“The approach is reproducible and scalable, capable of generating high numbers and IEQs of SC-islets without alteration in morphology, size, or off-target heterogeneity (Fig. 1c).”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Vertical-Wheel® suspension bioreactors promote islet cell differentiation and offers scale up capacity of human SC-islets
“This protocol generated SC-islet clusters of median size 77.06 µm (IQR: 54.30-106.2 µm; n = 210) in a 0.1 L vessel and 159.3 µm (IQR: 91.34–228.2 µm; n = 193) in a 0.5 L bioreactor vessel (Fig. 1c).”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets show in vitro functional potential and glucose-responsive insulin release
“Additionally, static incubation of S6w1 islets with low, high glucose, and KCl displayed a significant increase in insulin secretion. A thousand S6w1 cells produced a total of 4.9 ± 1.2 µIU insulin/ml in high glucose compared to 0.9 ± 0.2 µIU insulin/ml in low glucose (p = 0.0889; n = 4)”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets show in vitro functional potential and glucose-responsive insulin release
“*p < 0.05, **p < 0.001, and ****p < 0.00001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Methods > Evaluation of SC-islet graft function
“SC-islet grafts were retrieved by total nephrectomy three and/or 6 months after transplantation.”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Suspension SC-islets reverse diabetes after in vivo maturation
“We explanted grafts from 3 mice at 2-months (green) and 4 mice at 4-months (pink) post-transplantation”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > SC-islets exhibit single cell heterogeneity resembling to adult donor islets
“a total of 9 distinct clusters were identified on a UMAP projection”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > SC-islets exhibit single cell heterogeneity resembling to adult donor islets
“S6w1 cells were majorly clustered in 0, 1, 2, 4, and 5 clusters, whereas donor islets clustered in 0, 3, 4, 6, 7, 9, and 8.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Vertical-Wheel® suspension bioreactors promote islet cell differentiation and offers scale up capacity of human SC-islets
“The islet size distribution curve indicates that maximum clusters are generated within optimal islet diameter (<150 µm), and the frequency of large clusters is minimal across both scaling formats”
§ Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors > Results > Vertical-Wheel® suspension bioreactors promote islet cell differentiation and offers scale up capacity of human SC-islets
“159.3 µm (IQR: 91.34–228.2 µm; n = 193) in a 0.5 L bioreactor vessel”
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Bendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Segerstolpe, Å., Palasantza, A., Eliasson, P., Andersson, E.-M., Andréasson, A.-C., Sun, X., Picelli, S., Sabirsh, A., Clausen, M., Bjursell, M. K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.020 · Cited by 1,550
Baron, M., Veres, A., Wolock, S. L., Faust, A. L., Gaujoux, R., Vetere, A., Ryu, J. H., Wagner, B. K., Shen-Orr, S. S., Klein, A. M., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.08.011 · Cited by 1,508
A Single-Cell Transcriptome Atlas of the Human Pancreas
Muraro, M. J., Dharmadhikari, G., Grün, D., Groen, N., Dielen, T., Jansen, E., van Gurp, L., Engelse, M. A., Carlotti, F., de Koning, E. J. P., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.09.002 · Cited by 1,321
Cited by
Still being checked.
Metadata
- Authors
- Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., Anwar, P., Singh, A., Ray, N., O’ Gorman, D., Jickling, G., Lyon, J., MacDonald, P., & Shapiro, A. M. J.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Dadheech, Nidheesh
- Shapiro, A. M. James
- ORCID
- Venue
- npj Regenerative Medicine
- Published
- 2025-05-29
- Volume
- 10
- Issue
- 1
- Pages
- 24-24
- ISSN
- 2057-3995 (ISSN-L)
- PMC
- PMC12122946
- OpenAlex
- W4410851544
- Semantic Scholar
- 0a932a0d904867fd59d9398ded9ae9cd859b2b9e
- Cited by
- 23
- References
- 72
- Citations by year
- 2026: 20 · 2025: 3
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- npj Regenerative Medicine (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Juvenile Diabetes Research Foundation Canada
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- human induced pluripotent stem cells, stem cell-derived islets, vertical-wheel bioreactor, bioreactor scale-up, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, streptozotocin-induced diabetes, islet graft function, islet transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-16, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-16 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors. https://app.cochat.ai/papers/10.1038/s41536-025-00409-y
- The paper
- Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., Anwar, P., Singh, A., Ray, N., O’ Gorman, D., Jickling, G., Lyon, J., MacDonald, P., & Shapiro, A. M. J. (2025). Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors. npj Regenerative Medicine. https://doi.org/10.1038/s41536-025-00409-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.